Skip to Main Content

Author Details

Peter A Campochiaro
The Wilmer Eye Institute, Johns Hopkins University School of Medicine
1976
403
102
PMIDPaper TitleJournal TitlePublished Year
36736930Reduced inspired oxygen decreases retinal superoxide radicals and promotes cone function and survival in a model of retinitis pigmentosa.Free Radic Biol Med2023
37277613Peripheral photocoagulation not the answer for DMO.Eye (Lond)2023
36844452Anti-angiogenic collagen IV-derived peptide target engagement with α<sub>v</sub>β<sub>3</sub> and α<sub>5</sub>β<sub>1</sub> in ocular neovascularization models.iScience2023
34597713Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.Ophthalmology2022
35396185Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye.Trends Mol Med2022
35759124Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration.Ophthalmol Ther2022
35134532Oxidative stress-induced alterations in retinal glucose metabolism in Retinitis Pigmentosa.Free Radic Biol Med2022
34380366Using crowdsourcing to understand patients attitudes toward a clinical trial for retinitis pigmentosa requiring 4 years of participation.Ophthalmic Genet2022
32467630Comment on "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases".Eye (Lond)2021
33542456Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina.Gene Ther2021
34817536Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture.Invest Ophthalmol Vis Sci2021
34650670Eye of the Needle.Cerebrum2021
33380301The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.Curr Neuropharmacol2021
33248215Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases.Prog Retin Eye Res2021
32795434Locus-Level Changes in Macular Sensitivity in Patients with Retinitis Pigmentosa Treated with Oral N-acetylcysteine.Am J Ophthalmol2021
32259049Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization.FASEB Bioadv2020
32019921Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles.Nat Commun2020
31805012Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial.J Clin Invest2020
32017943Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.Microvasc Res2020
33308475Retinal vascular occlusions.Lancet2020
33184574Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases.Cell Mol Bioeng2020
32937452Suprachoroidal gene transfer with nonviral nanoparticles.Sci Adv2020
32708100Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.Int J Mol Sci2020
32895514Gelling hypotonic polymer solution for extended topical drug delivery to the eye.Nat Biomed Eng2020
32172031Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization.Biomaterials2020
30668550A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.JCI Insight2019
31635711Reply.Ophthalmology2019
31408444AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression.J Clin Invest2019
31577956A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization.Cell Rep2019
31374338Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.Acta Biomater2019
31232701Low risk to retina from sustained suppression of VEGF.J Clin Invest2019
31543350Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab.Ophthalmology2019
30954469Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.Am J Ophthalmol2019
30946888The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.Ophthalmology2019
30705041Classification of disease severity in retinitis pigmentosa.Br J Ophthalmol2019
30315650Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.J Neurochem2019
29292162AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration.Mol Ther2018
31047333Progression of Retinitis Pigmentosa as Measured on Microperimetry: The PREP-1 Study.Ophthalmol Retina2018
31047241Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study.Ophthalmol Retina2018
30383198Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.Invest Ophthalmol Vis Sci2018
29499174Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular Degeneration.Am J Ophthalmol2018
29769445VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models.JCI Insight2018
29686307Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models.Sci Rep2018
28962928The mechanism of cone cell death in Retinitis Pigmentosa.Prog Retin Eye Res2018
27710144Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.Hum Gene Ther2017
31047438Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration.Ophthalmol Retina2017
28282489Systematic Functional Testing of Rare Variants: Contributions of CFI to Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci2017
28081945Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.Ophthalmology2017
28100839Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.Sci Transl Med2017
28241318The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.Invest Ophthalmol Vis Sci2017
  • 1 - 50 of 403

Recommended Authors

Vaidehi S Dedania
Department of Ophthalmology at NYU Grossman School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Mohammad Dahrouj
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 1
Felicitas Bucher
Medical Center, University of Freiburg
Career Start Year 2010
Number of shared co-authors 2
Daniel Barthelmes
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 16
Caio V Regatieri
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 3
Jennifer R Chao
University of Washington
Career Start Year 2006
Number of shared co-authors 3
Christopher M Aderman
Wills Eye Hospital
Career Start Year 2006
Number of shared co-authors 3
Xialin Liu
Sun Yat-sen University
Career Start Year 2002
Number of shared co-authors 6
Hongjun Du
Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University
Career Start Year 1999
Number of shared co-authors 12
Andrew C Browning
Royal Victoria Infirmary
Career Start Year 1999
Number of shared co-authors 6
Yasuo Yanagi
Yokohama City University Medical Center
Career Start Year 1998
Number of shared co-authors 7
Glenn Yiu
University of California davis
Career Start Year 1998
Number of shared co-authors 5
Jost Hillenkamp
University Hospital Wurzburg
Career Start Year 1998
Number of shared co-authors 2
Marcus Fruttiger
UCL Institute of Ophthalmology
Career Start Year 1995
Number of shared co-authors 11
Robert F Mullins
the University of Iowa Carver College of Medicine
Career Start Year 1993
Number of shared co-authors 22
Edith Aguilar
the Scripps Research Institute
Career Start Year 1990
Number of shared co-authors 3
Michael W Stewart
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 6
Mark W Johnson
University of Michigan Kellogg Eye Center ann arbor
Career Start Year 1987
Number of shared co-authors 12
Marc D de Smet
MicroInvasive Ocular Surgery Clinic
Career Start Year 1987
Number of shared co-authors 7
Mark C Gillies
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 24
John O Mason
University of Alabama Callahan Eye Hospital and Clinics
Career Start Year 1986
Number of shared co-authors 1
Richard F Spaide
New York University Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 24
Thomas W Gardner
University of Michigan ann arbor
Career Start Year 1982
Number of shared co-authors 9
Akitoshi Yoshida
Asahikawa Medical University
Career Start Year 1981
Number of shared co-authors 12
William R Freeman
University of California San Diego
Career Start Year 1981
Number of shared co-authors 13
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 28
Martin Friedlander
the Scripps Research Institute
Career Start Year 1977
Number of shared co-authors 12
Thomas R Friberg
University of Pittsburgh
Career Start Year 1977
Number of shared co-authors 9
Lee M Jampol
Feinberg School of Medicine, Northwestern University
Career Start Year 1970
Number of shared co-authors 12
Stuart L Fine
Kaiser Permanente San Francisco Medical Center
Career Start Year 1965
Number of shared co-authors 10

Collaborators

Donald J Zack
Johns Hopkins University School of Medicine
Co-authored papers 58
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Co-authored papers 28
Julia A Haller
Wills Eye Hospital, and Thomas Jefferson University
Co-authored papers 24
Nicholas Katsanis
Northwestern University
Co-authored papers 11
Michele Melia
Jaeb Center for Health Research
Co-authored papers 11
Perciliz L Tan
Center for Human Disease Modeling, Duke University School of Medicine
Co-authored papers 8
Betsy Campochiaro
Johns Hopkins School of Medicine
Co-authored papers 7
Johanna M Seddon
University of Massachusetts Chan Medical School
Co-authored papers 6
Sun Young Lee
Chonbuk National University Hospital
Co-authored papers 6
Jiang Qian
Co-authored papers 6
Robyn Reynolds
Tufts University School of Medicine and Tufts Medical Center
Co-authored papers 6
Joseph T Coyle
Harvard Medical School and McLean Hospital
Co-authored papers 6
Stephan Ripke
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 5
Michael L Klein
Casey Eye Institute, Oregon Health & Science University
Co-authored papers 5
Eric H Souied
University of Paris Est-Creteil
Co-authored papers 5
Rando Allikmets
Columbia University Medical Center
Co-authored papers 5
Kang Zhang
College of Animal Science and Technology, Guangxi University
Co-authored papers 5
Gabri??lle H S Buitendijk
Erasmus Medical Center
Co-authored papers 5
Jesen Fagerness
Center for Human Genetic Research, Massachusetts General Hospital
Co-authored papers 5
George D Yancopoulos
Co-authored papers 5
Caroline C W Klaver
Erasmus Medical Center
Co-authored papers 5
Mark J Daly
Massachusetts General Hospital
Co-authored papers 5
Hendrik P N Scholl
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers 5
Roland Theodore Smith
Mount Sinai School of Medicine
Co-authored papers 5
Joanna E Merriam
Columbia University
Co-authored papers 5
Soumya Raychaudhuri
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 4
Yi Yu
Tufts Medical Center
Co-authored papers 4
Jennifer I Lim
University of Illinois at Chicago
Co-authored papers 4
Kimberly Chin
Boston Children's Hospital
Co-authored papers 4
Paul N Baird
The University of Melbourne
Co-authored papers 4
Release 1.2